FDA seeks feedback on generative AI regulations

By:
On:
URL has been copied successfully!

The agency published a discussion paper this week as it considers the “unique risks” and potential promise of generative AI for patient care.

Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here.